Efficacy of Autologous Bone Marrow Mononuclear Cell Transplantation in Treating Selective Type 2 Diabetes Mellitus
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bone marrow mononuclear cell therapy (Primary) ; Antihyperglycaemics; Insulin
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 03 Oct 2017 Biomarkers information updated
- 06 Sep 2012 New trial record